← Amentum overview

Amentum vs Equifax: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Amentum Holdings Inc. (AMTM)

Q3 2026
▲2▼2

Amentum wins big contracts but revenue misses and NASA cuts weigh

  • Major contract wins Amentum won NASA's COSMOS contract, joined a UK defence framework with Babcock, and secured nuclear deals including a $2.78 billion Sellafield framework and a Texas waste pilot, boosting its long-term backlog.

    These new contracts are a key positive force for the stock this quarter.

  • Profit beat and analyst upgrade Profit beat guidance and an analyst upgrade to Neutral lifted sentiment, showing the company can manage costs even as revenue falls short.

    This sentiment boost is a new positive driver for the quarter.

  • Revenue misses and NASA workforce cut Q2 and Q3 revenue missed expectations, and NASA's workforce directive will cut 2027 revenue by about 3%, raising concerns about near-term growth.

    These are new negative developments that pressured the stock.

  • Weak core growth and high valuation Core growth is weak—just 1.1% annually over four years with a 2.1% free cash flow margin—and analysts expect only 1.5% growth ahead, leaving limited upside despite contract wins.

    This fundamental weakness explains the stock's poor performance and cautious outlook.

August 2026
▲2▼1

Amentum's weak core results offset by nuclear contract wins and an upgrade

  • Weak revenue growth and cash flow weigh on the stock Amentum's revenue has barely grown — about 1.1% a year over four years — and its free cash flow margin averaged just 2.1%, leaving little money to reinvest. That weak core performance drove a 40.9% share price drop over six months, and analysts expect only 1.5% growth ahead.

    This is the central fundamental problem behind AMTM's decline and the backdrop for everything else.

  • Q3 earnings: profit beat, but revenue missed Amentum reported Q3 revenue of $3.49 billion, down 2% from a year earlier and below expectations, while earnings per share of $0.67 beat the $0.63 estimate. Both business segments beat on adjusted EBITDA, but the revenue shortfall sent shares down 6% and left the company the weakest performer among government consulting peers.

    The quarter is the period's key hard number: profit beat but shrinking revenue is the mixed signal driving sentiment.

  • Nuclear contract wins deepen long-term revenue base Amentum's joint venture OneAxIoM was named preferred supplier on a $2.78 billion Sellafield nuclear asset-care framework with a nine-year term, and Amentum joined a Texas nuclear waste disposal pilot that received a drilling permit. These long-duration nuclear deals could broaden revenue and support the company's growth story.

    These are the main new positive catalysts, showing where future revenue could come from.

  • Analyst upgrade gives a modest sentiment lift BNP Paribas Exane upgraded Amentum to Neutral, and the stock rose 3%. It is a small positive, but an upgrade to merely Neutral shows analysts still see limited upside after the weak results and slow growth.

    The upgrade is the period's only clear positive price reaction and shows sentiment stabilizing, though only slightly.

Latest
▲2▼1

Amentum's weak core results offset by nuclear contract wins and an upgrade

  • Weak revenue growth and cash flow weigh on the stock Amentum's revenue has barely grown — about 1.1% a year over four years — and its free cash flow margin averaged just 2.1%, leaving little money to reinvest. That weak core performance drove a 40.9% share price drop over six months, and analysts expect only 1.5% growth ahead.

    This is the central fundamental problem behind AMTM's decline and the backdrop for everything else.

  • Q3 earnings: profit beat, but revenue missed Amentum reported Q3 revenue of $3.49 billion, down 2% from a year earlier and below expectations, while earnings per share of $0.67 beat the $0.63 estimate. Both business segments beat on adjusted EBITDA, but the revenue shortfall sent shares down 6% and left the company the weakest performer among government consulting peers.

    The quarter is the period's key hard number: profit beat but shrinking revenue is the mixed signal driving sentiment.

  • Nuclear contract wins deepen long-term revenue base Amentum's joint venture OneAxIoM was named preferred supplier on a $2.78 billion Sellafield nuclear asset-care framework with a nine-year term, and Amentum joined a Texas nuclear waste disposal pilot that received a drilling permit. These long-duration nuclear deals could broaden revenue and support the company's growth story.

    These are the main new positive catalysts, showing where future revenue could come from.

  • Analyst upgrade gives a modest sentiment lift BNP Paribas Exane upgraded Amentum to Neutral, and the stock rose 3%. It is a small positive, but an upgrade to merely Neutral shows analysts still see limited upside after the weak results and slow growth.

    The upgrade is the period's only clear positive price reaction and shows sentiment stabilizing, though only slightly.

July 2026
▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

  • NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.

    New contract award directly boosts AMTM's demand outlook.

  • Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.

    This is the main earnings event that moved the stock sharply both ways.

  • UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.

    New contract expands AMTM's addressable market and revenue visibility.

  • NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.

    It is a new, specific negative factor that tempers the positive outlook.

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

  • NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.

    New contract award directly boosts AMTM's demand outlook.

  • Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.

    This is the main earnings event that moved the stock sharply both ways.

  • UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.

    New contract expands AMTM's addressable market and revenue visibility.

  • NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.

    It is a new, specific negative factor that tempers the positive outlook.

Equifax Inc (EFX)

Q3 2026
▲2▼2

Equifax grew but faced pricing and margin pressures

  • Strong revenue and earnings beat Equifax beat Q2 earnings with revenue up 10.6%, mortgage revenues up 40%, and USIS up 17%, showing robust demand across key segments.

    This point highlights the positive financial performance that likely supported the stock price.

  • AI cost savings and acquisitions Equifax doubled AI cost savings targets to $150 million, agreed to acquire Mexico's Círculo de Crédito for $750 million, and launched a healthcare credentialing product, signaling growth initiatives.

    These strategic moves demonstrate efforts to boost efficiency and expand into new markets.

  • Regulatory changes pressure pricing FHFA reforms ended FICO's monopoly, allowing VantageScore, and Equifax locked mortgage scores at $1 through 2028, pressuring pricing. A possible bi-merge requirement could cut demand for three-bureau reports.

    These regulatory shifts directly threaten Equifax's pricing power and demand for its core products.

  • Margin declines and rising leverage Margins fell across all segments amid weak mortgage markets and rising costs. Equifax also added $1 billion in debt after heavy buybacks, raising leverage concerns.

    Deteriorating margins and increased debt could weigh on investor sentiment and financial flexibility.

August 2026
▲2▼2

Equifax's mortgage pricing power shrinks as VantageScore push and debt load weigh

  • Mortgage pricing pressure from VantageScore adoption Equifax is holding VantageScore 4.0 mortgage scores at just $1 through 2028, and nearly 2,000 lenders have adopted it. This locks in very low pricing for a key product, which can shrink revenue per mortgage even as volumes grow. The earlier FHFA reforms that ended FICO's monopoly are the root cause, and this pricing move confirms the pressure is real and lasting.

    This is the biggest new development directly affecting Equifax's mortgage revenue and pricing power.

  • Rising debt load from $1 billion bond sale Equifax raised $1 billion in new debt in August, adding to leverage after buying back $1.49 billion of stock since April 2025. Higher interest costs can eat into profits if earnings don't grow fast enough. Analysts already flag the company's high debt level, so this makes the balance sheet a bigger risk.

    New debt issuance increases financial risk and interest costs, a key factor for investors.

  • Strong Q2 earnings and raised AI savings target Equifax beat second-quarter earnings and revenue estimates, with mortgage revenues up 40% and USIS revenues up 17%. Management doubled its AI-driven cost savings target to $150 million and agreed to buy Mexico's Circulo de Credito for $750 million. This shows the core business is growing and cost cuts are helping profits.

    This is the most important positive fundamental news for Equifax this period.

  • New healthcare screening product expands verification business Equifax launched Healthcare Report Credential ID, an automated tool to verify healthcare licenses and certifications. With projected shortages of over 106,000 doctors and 267,000 nurses by 2027, hospitals need faster onboarding. This adds a new product to Equifax's fast-growing verification services, which already drive much of its profit growth.

    New product launch shows Equifax expanding its higher-margin verification business beyond traditional credit reports.

Latest
▲2▼2

Equifax's mortgage pricing power shrinks as VantageScore push and debt load weigh

  • Mortgage pricing pressure from VantageScore adoption Equifax is holding VantageScore 4.0 mortgage scores at just $1 through 2028, and nearly 2,000 lenders have adopted it. This locks in very low pricing for a key product, which can shrink revenue per mortgage even as volumes grow. The earlier FHFA reforms that ended FICO's monopoly are the root cause, and this pricing move confirms the pressure is real and lasting.

    This is the biggest new development directly affecting Equifax's mortgage revenue and pricing power.

  • Rising debt load from $1 billion bond sale Equifax raised $1 billion in new debt in August, adding to leverage after buying back $1.49 billion of stock since April 2025. Higher interest costs can eat into profits if earnings don't grow fast enough. Analysts already flag the company's high debt level, so this makes the balance sheet a bigger risk.

    New debt issuance increases financial risk and interest costs, a key factor for investors.

  • Strong Q2 earnings and raised AI savings target Equifax beat second-quarter earnings and revenue estimates, with mortgage revenues up 40% and USIS revenues up 17%. Management doubled its AI-driven cost savings target to $150 million and agreed to buy Mexico's Circulo de Credito for $750 million. This shows the core business is growing and cost cuts are helping profits.

    This is the most important positive fundamental news for Equifax this period.

  • New healthcare screening product expands verification business Equifax launched Healthcare Report Credential ID, an automated tool to verify healthcare licenses and certifications. With projected shortages of over 106,000 doctors and 267,000 nurses by 2027, hospitals need faster onboarding. This adds a new product to Equifax's fast-growing verification services, which already drive much of its profit growth.

    New product launch shows Equifax expanding its higher-margin verification business beyond traditional credit reports.

September 2026
▼4

FHFA Reforms Threaten Equifax's Mortgage Credit Reporting Business

  • FHFA Ends FICO Monopoly, VantageScore Allowed The FHFA directed Fannie Mae and Freddie Mac to let all lenders use VantageScore, ending FICO's monopoly. Equifax shares fell 6.8% as investors worried about pricing pressure on credit reports, even though Equifax co-owns VantageScore.

    This regulatory change directly threatens Equifax's mortgage credit reporting revenue and sparked the initial sell-off.

  • FHFA Unifies Mortgage Pricing Grid The FHFA announced a single pricing grid for Fannie and Freddie mortgages that includes VantageScore alongside FICO. Equifax fell 4.1% premarket as the move escalates pressure on credit bureau fees and could reduce revenue per mortgage.

    This is a new escalation that directly impacts Equifax's mortgage pricing and was not in earlier reports.

  • FHFA May Require Two Credit Bureaus (Bi-Merge) A Bloomberg report says the FHFA may require lenders to use two credit bureaus instead of three for mortgages. This would cut demand for Equifax's traditional three-bureau reports, pressuring volumes and pricing. The rule could be announced as soon as Oct. 12.

    This potential rule change is a new threat that could significantly reduce Equifax's mortgage report volumes.

  • Equifax Faces Mortgage Score Pressure as Fannie and Freddie Add VantageScore Fannie and Freddie are adding VantageScore to mortgage underwriting, and major lenders like Rocket Mortgage are preparing to adopt it. This could shift demand away from traditional credit reports and pressure Equifax's mortgage fee mix and volumes.

    This article summarizes the competitive pressure and potential revenue mix shift, reinforcing the negative outlook.

▼4

FHFA Reforms Threaten Equifax's Mortgage Credit Reporting Business

  • FHFA Ends FICO Monopoly, VantageScore Allowed The FHFA directed Fannie Mae and Freddie Mac to let all lenders use VantageScore, ending FICO's monopoly. Equifax shares fell 6.8% as investors worried about pricing pressure on credit reports, even though Equifax co-owns VantageScore.

    This regulatory change directly threatens Equifax's mortgage credit reporting revenue and sparked the initial sell-off.

  • FHFA Unifies Mortgage Pricing Grid The FHFA announced a single pricing grid for Fannie and Freddie mortgages that includes VantageScore alongside FICO. Equifax fell 4.1% premarket as the move escalates pressure on credit bureau fees and could reduce revenue per mortgage.

    This is a new escalation that directly impacts Equifax's mortgage pricing and was not in earlier reports.

  • FHFA May Require Two Credit Bureaus (Bi-Merge) A Bloomberg report says the FHFA may require lenders to use two credit bureaus instead of three for mortgages. This would cut demand for Equifax's traditional three-bureau reports, pressuring volumes and pricing. The rule could be announced as soon as Oct. 12.

    This potential rule change is a new threat that could significantly reduce Equifax's mortgage report volumes.

  • Equifax Faces Mortgage Score Pressure as Fannie and Freddie Add VantageScore Fannie and Freddie are adding VantageScore to mortgage underwriting, and major lenders like Rocket Mortgage are preparing to adopt it. This could shift demand away from traditional credit reports and pressure Equifax's mortgage fee mix and volumes.

    This article summarizes the competitive pressure and potential revenue mix shift, reinforcing the negative outlook.

July 2026
▲2▼1

Equifax Expands in Mexico and AI Savings, but Margin Pressures Weigh

  • Mexico Acquisition Expands Footprint Equifax agreed to buy Mexico's Círculo de Crédito for $750 million, adding a fast-growing credit bureau with $134 million in revenue and 46% EBITDA margin. This should boost future earnings and opens a new market, but regulatory approval is pending.

    This is a major new growth driver that directly affects EFX's future revenue and earnings.

  • Q2 Earnings Beat but Guidance Disappoints Equifax reported Q2 revenue up 10.6% and adjusted EPS of $2.25, beating estimates. However, full-year and Q3 guidance came in below analyst expectations, sending the stock down 7%. The weak outlook is tied to a shrinking mortgage market.

    This is the key new financial report that shows current performance and future expectations, directly impacting investor sentiment.

  • AI Savings Target Doubled to $150 Million Equifax doubled its AI-driven cost savings goal to $150 million for 2026-2028, using AI to improve efficiency. This should help offset margin pressures and boost profitability over time.

    This is a new strategic initiative that could improve future margins and profitability.

  • Margin Pressures and Weak Mortgage Market Despite revenue growth, adjusted EBITDA margins fell across all segments, and rising compensation and tech costs are squeezing profits. The mortgage market remains weak with high rates, hurting a key revenue source.

    This explains the negative stock reaction and highlights ongoing challenges that could limit upside.

▲2▼1

Equifax Expands in Mexico and AI Savings, but Margin Pressures Weigh

  • Mexico Acquisition Expands Footprint Equifax agreed to buy Mexico's Círculo de Crédito for $750 million, adding a fast-growing credit bureau with $134 million in revenue and 46% EBITDA margin. This should boost future earnings and opens a new market, but regulatory approval is pending.

    This is a major new growth driver that directly affects EFX's future revenue and earnings.

  • Q2 Earnings Beat but Guidance Disappoints Equifax reported Q2 revenue up 10.6% and adjusted EPS of $2.25, beating estimates. However, full-year and Q3 guidance came in below analyst expectations, sending the stock down 7%. The weak outlook is tied to a shrinking mortgage market.

    This is the key new financial report that shows current performance and future expectations, directly impacting investor sentiment.

  • AI Savings Target Doubled to $150 Million Equifax doubled its AI-driven cost savings goal to $150 million for 2026-2028, using AI to improve efficiency. This should help offset margin pressures and boost profitability over time.

    This is a new strategic initiative that could improve future margins and profitability.

  • Margin Pressures and Weak Mortgage Market Despite revenue growth, adjusted EBITDA margins fell across all segments, and rising compensation and tech costs are squeezing profits. The mortgage market remains weak with high rates, hurting a key revenue source.

    This explains the negative stock reaction and highlights ongoing challenges that could limit upside.